Browse our wide selection of products for your research needs
Product Infomation | |
---|---|
Catalog Number | BIOD-010 |
Product Name | PDLGA Granule |
Product overview | This product is a granular copolymer of DL-lactide and glycolide (PDLGA), which meets the GMP standard in the pharmaceutical field and can be directly used in the production of medical devices or pharmaceutical preparations. |
Morphology & Appearance | White or light yellow particles |
Viscosity | DL-lactide and glycolide copolymer, molar ratio 50/50: 0.2 dl/g DL-lactide and glycolide copolymer, molar ratio 50/50: 1.0 dl/g DL-lactide and glycolide copolymer, molar ratio 75/25: 0.2 dl/g DL-lactide and glycolide copolymer, molar ratio 75/25: 0.7 dl/g |
Storage | Store at 4°C. |
Application | Drug release: PDLGA has good biocompatibility, non-toxicity, good encapsulation and film-forming properties, and is widely used in pharmaceuticals; for example, PDLGA nanoparticles have high encapsulation efficiency for active drugs, which can improve their stability and bioavailability, commonly used in drug sustained release systems; Tissue engineering: PDLGA microspheres or fibrous porous scaffolds have the characteristics of adjustable porosity, pore size and degradation rate, which can be used as scaffolds for cell culture and carriers of drug components, and can be implanted in vivo for blood vessels, nerves, Bone and other tissue engineering fields; Medical devices: PDLGA has good compatibility and degradability, and can be used to produce disposable infusion sets, detachable surgical sutures, etc.; |